155 related articles for article (PubMed ID: 6149343)
1. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period.
Klintmalm G; Bohman SO; Sundelin B; Wilczek H
Lancet; 1984 Oct; 2(8409):950-4. PubMed ID: 6149343
[TBL] [Abstract][Full Text] [Related]
2. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies.
Ruiz P; Kolbeck PC; Scroggs MW; Sanfilippo F
Transplantation; 1988 Jan; 45(1):91-5. PubMed ID: 3276070
[TBL] [Abstract][Full Text] [Related]
3. Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin.
Farnsworth A; Hall BM; Ng AB; Duggin GG; Horvath JS; Sheil AG; Tiller DJ
Am J Surg Pathol; 1984 Apr; 8(4):243-52. PubMed ID: 6369996
[TBL] [Abstract][Full Text] [Related]
4. Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies.
Verani RR; Flechner SM; Van Buren CT; Kahan BD
Am J Kidney Dis; 1984 Sep; 4(2):185-91. PubMed ID: 6383031
[TBL] [Abstract][Full Text] [Related]
5. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.
Neild GH; Taube DH; Hartley RB; Bignardi L; Cameron JS; Williams DG; Ogg CS; Rudge CJ
J Clin Pathol; 1986 Feb; 39(2):152-9. PubMed ID: 3512613
[TBL] [Abstract][Full Text] [Related]
6. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin and renal graft histology.
d'Ardenne AJ; Dunnill MS; Thompson JF; McWhinnie D; Wood RF; Morris PJ
J Clin Pathol; 1986 Feb; 39(2):145-51. PubMed ID: 3512612
[TBL] [Abstract][Full Text] [Related]
8. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
Diethelm AG
Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation.
Rynasiewicz JJ; Sutherland DE; Ferguson RM; Squifflet JP; Morrow CE; Goetz FC; Najarian JS
Diabetes; 1982 Aug; 31 Suppl 4():92-108. PubMed ID: 6819969
[TBL] [Abstract][Full Text] [Related]
10. Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
Sommer BG; Sing DE; Henry ML; Ferguson RM; Orosz CG
Transplantation; 1988 Jan; 45(1):86-90. PubMed ID: 3276069
[TBL] [Abstract][Full Text] [Related]
11. High- and low-dose regimens of cyclosporin in renal transplantation: immunosuppressive efficacy and side-effects.
Kootte AM; Lensen LM; van Bockel JH; van Es LA; Paul LC
Nephrol Dial Transplant; 1988; 3(5):666-70. PubMed ID: 3146726
[TBL] [Abstract][Full Text] [Related]
12. Histopathological changes in cyclosporin-treated renal allografts biopsied at one and twelve months.
Bignardi L; Neild GH; Hartley RB; Taube DH; Cameron JS; Rudge CJ; Williams DG; Ogg CS
Nephrol Dial Transplant; 1987; 2(5):366-70. PubMed ID: 3122115
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
[TBL] [Abstract][Full Text] [Related]
14. Development of chronic renal cyclosporin-A toxicity.
Klintmalm G
Nephrologie; 1987; 8(3):131-3. PubMed ID: 3309701
[TBL] [Abstract][Full Text] [Related]
15. Definition, diagnosis, and management of rejection in the second to sixth months posttransplant--an overview.
Matas AJ; Tellis VA; Quinn T; Soberman R; Veith FJ
Transplant Proc; 1986 Apr; 18(2 Suppl 1):141-50. PubMed ID: 3515682
[TBL] [Abstract][Full Text] [Related]
16. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
17. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.
Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437
[TBL] [Abstract][Full Text] [Related]
18. Maintenance cyclosporin monotherapy after renal transplantation--clinical predictors of long-term outcome.
Touchard G; Hauet T; Cogny Van Weydevelt F; Hurault de Ligny B; Peyronnet P; Lebranchu Y; Toupance O; N'Doye P; Busson M
Nephrol Dial Transplant; 1997 Sep; 12(9):1956-60. PubMed ID: 9306349
[TBL] [Abstract][Full Text] [Related]
19. Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney.
Leunissen KM; Bosman FT; Nieman FH; Kootstra G; Vromen MA; Noordzij TC; van Hooff JP
Transplantation; 1989 Oct; 48(4):590-3. PubMed ID: 2799911
[TBL] [Abstract][Full Text] [Related]
20. [Biopsy findings in kidney transplants after treatment with cyclosporin A].
Nizze H; Gokel JM; Lang W; Mihatsch MJ
Zentralbl Allg Pathol; 1986; 132(5-6):423-33. PubMed ID: 3551394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
